£795.00

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

2023-2028 World Outlook for RNA-Based Therapeutics Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 37 days · 37 data points (no recent data)

Historical
Generating forecast…
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 23 August 2026 01 September 2026 10 September 2026 19 September 2026 28 September 2026
View at Amazon ↗

Price data last checked 54 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 37 days • 1 price levels

Days at Price
37 days 0 9 19 28 37 £795 Days at Price

Price Analysis

Most common price: £795 (37 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 37 days

Description

This comprehensive market research report analyses the global outlook for RNA-based therapeutics across more than 190 countries through 2028. The study provides detailed estimates of latent demand and potential industry earnings (P.I.E.) in millions of U.S. dollars for each country, along with percentage shares relative to regional and global markets. Using econometric models that project fundamental economic dynamics, the report delivers comparative benchmarks to help readers assess each country's position within the RNA therapeutics industry. The data enables strategic planning and market assessment across all major economies and emerging markets worldwide.

Key Features

Covers RNA-based therapeutics market data for more than 190 countries with country-specific latent demand and P.I.E. estimates.

Provides percentage share calculations showing each country's position relative to its region and the global RNA-based therapeutics market.

Uses econometric models to project economic dynamics and generate accurate latent demand forecasts through 2028.

Includes comparative benchmarks that allow rapid assessment of any country versus competitors in the RNA therapeutics sector.

Published by ICON Group International, Inc., offering authoritative market intelligence for the RNA-based therapeutics industry.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
17 June 2022
Listed Since
13 May 2022

Similar Products You Might Like

The 2023-2028 World Outlook for Therapeutic Cancer Vaccines
89% match

The 2023-2028 World Outlook for Therapeutic Cancer Vaccines

£795.00 13 Sep 2026
The 2023-2028 World Outlook for Pharma Contract Sales
88% match

The 2023-2028 World Outlook for Pharma Contract Sales

£795.00 15 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States
88% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Renal Anemia Treatments in the United States
87% match

The 2023-2028 Outlook for Renal Anemia Treatments in the United States

£520.00 27 Sep 2026
The 2023-2028 World Outlook for Virology
87% match

The 2023-2028 World Outlook for Virology

£795.00 12 Nov 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in the United States
87% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in the United States

£520.00 27 Sep 2026
2023-2028 World Outlook for Sickle Cell Disease Treatments
87% match

2023-2028 World Outlook for Sickle Cell Disease Treatments

£795.00 28 Sep 2026
The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in the United States
87% match

The 2023-2028 Outlook for Oncolytic Virus Immunotherapies in the United States

£520.00 27 Sep 2026
The 2026-2031 World Outlook for Potential Analysis of Human DNA Vaccines
87% match

The 2026-2031 World Outlook for Potential Analysis of Human DNA Vaccines

£885.00 28 Sep 2026
The 2027-2032 World Outlook for Biodefense
87% match

The 2027-2032 World Outlook for Biodefense

£890.00 22 Sep 2026
The 2023-2028 World Outlook for Pharma Track and Trace Solutions
87% match

The 2023-2028 World Outlook for Pharma Track and Trace Solutions

£795.00 15 Sep 2026
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
87% match

The 2023-2028 Outlook for Hepatitis Therapeutics in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Biologic Vasculitis Treatments in India
87% match

The 2023-2028 Outlook for Biologic Vasculitis Treatments in India

£515.00 27 Sep 2026
2023-2028 World Outlook for Viral Infections - Global Market Report
87% match

2023-2028 World Outlook for Viral Infections - Global Market Report

£795.00 28 Sep 2026
The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States
87% match

The 2023-2028 Outlook for Nucleotide Polymerase Inhibitor Antiviral Drugs in the United States

£520.00 27 Sep 2026
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
87% match

The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States

£520.00 27 Sep 2026
2026-2031 World Outlook for Biotherapeutics Cell Line Developments
87% match

2026-2031 World Outlook for Biotherapeutics Cell Line Developments

£885.00 28 Sep 2026
The 2023-2028 Outlook for Vasculitis Treatments in India
87% match

The 2023-2028 Outlook for Vasculitis Treatments in India

£515.00 27 Sep 2026
The 2023-2028 World Outlook for Generic Antiviral Drugs
87% match

The 2023-2028 World Outlook for Generic Antiviral Drugs

£795.00 15 Sep 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in India
87% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in India

£515.00 27 Sep 2026
The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs
86% match

The 2023-2028 World Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs

£795.00 15 Sep 2026
The 2023-2028 Outlook for Orphan Biologic Drugs in India
86% match

The 2023-2028 Outlook for Orphan Biologic Drugs in India

£515.00 27 Sep 2026
The 2023-2028 Outlook for Rheumatology Therapeutics in India
86% match

The 2023-2028 Outlook for Rheumatology Therapeutics in India

£515.00 27 Sep 2026
The 2026-2031 World Outlook for Drug Repurposing
86% match

The 2026-2031 World Outlook for Drug Repurposing

£885.00 28 Sep 2026